These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 18502261

  • 1. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T, Okubo M, Amemiya-Kudo M, Ebara T, Mori Y.
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [Abstract] [Full Text] [Related]

  • 2. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
    Murase T, Okubo M, Amemiya-Kudo M, Hiraga T, Oka J, Shimada M, Igarashi T.
    Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
    [Abstract] [Full Text] [Related]

  • 3. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
    Nogués X, Sentí M, Pedro-Botet J, Molina L, Serrat R, Pons S, Rubiés-Prat J.
    Med Clin (Barc); 1992 Feb 08; 98(5):171-4. PubMed ID: 1532436
    [Abstract] [Full Text] [Related]

  • 4. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A, Castaldo M, Sardo A, Cinquegrani M, Bonaiuto M, Zema M, Gravina M, Mangano C.
    Minerva Med; 1999 Feb 08; 90(5-6):151-8. PubMed ID: 10780189
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
    Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G.
    J Clin Invest; 1992 Mar 08; 89(3):1040-6. PubMed ID: 1541665
    [Abstract] [Full Text] [Related]

  • 6. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
    Imhof A, Rothenbacher D, Khuseyinova N, Hoffmeister A, Maerz W, Nauck M, Scharnagl H, Koenig W, Brenner H.
    Eur J Cardiovasc Prev Rehabil; 2003 Oct 08; 10(5):362-70. PubMed ID: 14663298
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein(a) and coronary heart disease in Indian population.
    Singh S, Dwivedi S, Melkani GC, Rani C, Gaur SP, Mandal SK, Mahua J.
    J Assoc Physicians India; 1999 Dec 08; 47(12):1157-60. PubMed ID: 11225215
    [Abstract] [Full Text] [Related]

  • 8. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
    Rajmohan L, Deepa R, Mohan A, Mohan V.
    Indian Heart J; 2000 Dec 08; 52(4):400-6. PubMed ID: 11084779
    [Abstract] [Full Text] [Related]

  • 9. [Lp(a) serum concentrations in diabetes mellitus].
    Murakami J, Kumasaka K, Kawano K, Murakami T, Hayashi Y, Arakawa Y.
    Rinsho Byori; 1994 Dec 08; 42(12):1273-8. PubMed ID: 7869592
    [Abstract] [Full Text] [Related]

  • 10. High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus.
    Habib SS, Aslam M.
    Saudi Med J; 2003 Jun 08; 24(6):647-51. PubMed ID: 12847596
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
    Deepa R, Mohan A, Rema M, Haranath SP, Saravanan G, Mohan V.
    J Assoc Physicians India; 2002 May 08; 50(5):657-61. PubMed ID: 12186119
    [Abstract] [Full Text] [Related]

  • 12. Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus.
    Wakabayashi I, Masuda H.
    Clin Chim Acta; 2006 Nov 08; 373(1-2):127-31. PubMed ID: 16820145
    [Abstract] [Full Text] [Related]

  • 13. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G, Cuomo S, Capozzi G, Foglia MC, Barra S, Madrid A, Stornaiuolo V, Trevisan M.
    Nutr Metab Cardiovasc Dis; 2008 Sep 08; 18(7):492-6. PubMed ID: 17962002
    [Abstract] [Full Text] [Related]

  • 14. Association between incidence of lipoprotein(a) positivity and coronary heart disease.
    Vashisht S, Wasir H, Srivastava LM.
    Indian Heart J; 1992 Sep 08; 44(4):223-6. PubMed ID: 1289218
    [Abstract] [Full Text] [Related]

  • 15. Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease.
    Maca T, Mlekusch W, Doweik L, Budinsky AC, Bischof M, Minar E, Schillinger M.
    Eur J Clin Invest; 2007 Mar 08; 37(3):180-6. PubMed ID: 17359485
    [Abstract] [Full Text] [Related]

  • 16. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
    Tarkun I, Cetinarslan B, Cantürk Z.
    Nutr Metab Cardiovasc Dis; 2002 Jun 08; 12(3):127-31. PubMed ID: 12325469
    [Abstract] [Full Text] [Related]

  • 17. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
    Ben Hamda K, Masmoudi AS, Mandhouj O, Hammami S, Attia N, Smaoui M, Zidi MA, Nabli N, Chaaba R, Mahjoub S, Ben Farhat M, Hammami M.
    Arch Inst Pasteur Tunis; 2002 Jun 08; 79(1-4):27-33. PubMed ID: 15072242
    [Abstract] [Full Text] [Related]

  • 18. [Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk].
    Samuelsson O, Pennert K, Andersson O, Berglund G, Hedner T, Persson B, Wedel H, Wilhelmsen L.
    Lakartidningen; 1998 Mar 11; 95(11):1120-3. PubMed ID: 9542820
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
    Kim SH, Chunawala L, Linde R, Reaven GM.
    J Am Coll Cardiol; 2006 Jul 18; 48(2):293-7. PubMed ID: 16843178
    [Abstract] [Full Text] [Related]

  • 20. The importance of Lp(a)-fibronectin interaction in atherogenesis.
    Sönmez H, Süer S, Kökoğlu E, Dirican A, Ulutin T, Uçişik N, Ulutin ON.
    Haematologia (Budap); 1997 Jul 18; 28(3):149-53. PubMed ID: 9283915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.